Products for Research Use Only
RegisterLogin

JGK-263

CAT: 0804-HY-114270Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-114270Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
JGK-263 is an orally active Glycogen synthase kinase-3β (GSK-3β) inhibitor. JGK-263 exhibits neuroprotective effect and can improve motor function. JGK-263 can be used for the research of neurological disease, such as amyotrophic lateral sclerosis (ALS) [1].
CAS Number
1408054-46-5
UNSPSC
12352005
Target
GSK-3
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Field of Research
Neurological Disease
Smiles
O=C1NN=C2C(NCCCC3=CC=NC=C3)=CC(Cl)=CN21
Molecular Formula
C14H14ClN5O
Molecular Weight
303.75
References & Citations
[1]Ahn SW, et al. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis. J Neurol Sci. 2014 May 15;340 (1-2) :112-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GSK-3β

Related Products

CatalogName
HY-153744JGK-068S
HY-135843-01TH-263
HY-123019RA-263
HY-168886Anticancer agent 263
HY-168478Antibacterial agent 263
HY-W953261CRBN ligand-263
HY-P701036Siglec-15, Cynomolgus (Biotinylated, 263a.a, HEK293, His-Avi)

Alternative Products

CatalogName
T79124-01JGK-068S
T9295-01BLU-263
2467-25ABT-263
TRC-A112500-5MGABT 263
MBS5756123TH-263
NMA52094-01TH 263
GTR19192967-01RA 263

Popular Products